Centessa Pharmaceuticals

14.57
0.06 (0.41%)
At close: Mar 28, 2025, 3:59 PM
13.62
-6.52%
Pre-market: Mar 31, 2025, 04:29 AM EDT

Centessa Pharmaceuticals Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -8.13 -5.07 -1.34 -2.65 -279.84 -291.8
PEG Ratio -0.26 0.16 0.03 -0.00 -65.15 n/a
PS Ratio n/a 111.71 n/a n/a n/a n/a
PB Ratio 4.78 3.24 0.86 2.06 -137.79 n/a
P/FCF Ratio -13.49 -4.77 -1.44 -7.43 -290.66 -264.7
P/OCF Ratio -13.5 -4.77 -1.44 -7.44 -290.66 -264.7
OCF/S Ratio n/a -23.4 n/a n/a n/a n/a
Debt / Equity Ratio 0.02 0.36 0.21 0.15 -0.25 n/a
Quick Ratio 9.25 8.00 11.05 24.88 1.18 n/a
Current Ratio 9.25 8.00 10.27 24.15 1.30 n/a
Asset Turnover n/a 0.02 n/a n/a n/a n/a
Interest Coverage 19.93 -17.29 -30.18 -54.66 -27.62 -42.82
Return on Equity (ROE) -0.59 -0.64 -0.64 -0.78 0.49 n/a
Return on Assets (ROA) -0.41 -0.42 -0.49 -0.61 -0.94 n/a
Return on Capital (ROIC) -0.39 -0.53 -0.52 -0.23 -3.37 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a 100.00% n/a n/a n/a n/a
Net Profit Margin n/a -2.2K% n/a n/a n/a n/a
Pretax Profit Margin n/a -2.57K% n/a n/a n/a n/a
Operating Profit Margin n/a -2.5K% n/a n/a n/a n/a
FCF Margin n/a -2.34K% n/a n/a n/a n/a
EBITDA Margin n/a -2.42K% n/a n/a n/a n/a